Recent Initiatives

On the Driven to Discover podcast, Henry Louis Taylor explains how transforming neighborhoods will improve health outcomes
12/18/24
In this episode of UB’s research podcast Driven to Discover, Henry-Louis Taylor, Jr., talks about what led him to launch his latest and most ambitious project: The East Side Neighborhood Transformation Project.
Two UB studies on MS patients reveal how paramagnetic rim lesions evolve and what they mean for disease progression
12/11/24
UB researchers have published the first longitudinal studies of paramagnetic rim lesions, an indicator of brain inflammation in MS.
UB expert part of FDA committee that looked at AI-enabled medical devices
12/9/24
Peter Elkin was invited to serve on the FDA's Digital Health Advisory Committee.
UB team visits community health partners in Africa to develop drugs to fight HIV, TB
12/6/24
Trip includes laboratory tours, meetings at universities in Zimbabwe and South Africa.
Leveraging AI to analyze social determinants of health
12/6/24
UB researcher receives $1 million funding award from the Patient-Centered Outcomes Research Institute (PCORI) for project that could impact multiple medical conditions, including opioid use disorder.
UB pediatric surgeon performs life-changing procedure on newborn
12/3/24
Mandibular distraction, led by UB’s Michael Markiewicz, enables Israeli baby to breathe, eat on her own.
Henry Louis Taylor Jr. on Changing the Black East Side
12/3/24
As a young clinical audiologist, Henry Louis Taylor Jr. found that the socioeconomic realities of many of his Black patients affected his ability to help them. To truly serve his community, he realized, he would need to understand the root causes of their circumstances. So he quit his job and went back to school to study urban history. Now, as the founding director of UB’s Center for Urban Studies at the School of Architecture and Planning, and associate director of the Community Health Equity Research Institute at the Jacobs School of Medicine and Biomedical Sciences, Taylor is on a mission to reverse the historic inequities that have created such a wide gap between Black lives and white lives. In this episode, the self-proclaimed activist scholar talks to host Ellen Goldbaum about his latest and most ambitious effort: The East Side Neighborhood Transformation Project.
NEJM study: For chronic subdural hematomas, blocking the artery supplying the brain covering reduced re-operations threefold
11/20/24
A dramatic reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to results published in the New England Journal of Medicine.
UB team receives grant to study hospital complications in children with special health care needs
11/18/24
Researchers will interview parents and caregivers to learn about their experiences.
How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how
11/13/24
UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication alleviates symptoms of major depression in as little as a few hours.
UB dental school receives $7.3 million NIH grant to develop germ-free microbiome research facility
11/7/24
Center will provide for groundbreaking work open to researchers across disciplines.
UB team studies whether structured financial incentives can help lower disease risk in African Americans facing food insecurity
11/6/24
UB researchers have received a $$3.28 million grant from the NIH to investigate the use of structured financial incentives in lowering cardiovascular disease (CVD) risk among African Americans facing food insecurity.
Researchers show why cannabis policies should shift to a harm reduction, health promotion approach
10/23/24
A paper published today explains why there needs to be a shift in cannabis policies to a public health approach as opposed to the prevailing, more punitive approach that pushes abstinence instead of public education.
Severe MS: Researchers report findings from some of the first studies conducted on patients with this rare form of the disease
10/23/24
UB research that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
What’s the secret to resilient aging? Innovative UB center aims to find out
10/16/24
UB's new Aging and Resilience Research Center on The Brothers of Mercy Wellness Campus in Clarence, N.Y. is dedicated to identifying the factors that contribute to healthy, resilient aging.
JAMA study: Living in a redlined neighborhood in 1940 was a risk factor for premature death
10/9/24
People living in redlined neighborhoods in 1940 didn’t live as long as those living in neighborhoods with access to credit and home loans.
Donald Mager receives prestigious lifetime award from International Society of Pharmacometrics
10/9/24
A research leader in systems pharmacology and pharmacodynamics, Mager will be recognized Sunday, Nov. 10, during the 2024 American Conference on Pharmacometrics at the Arizona Grand Resort and Spa in Phoenix.
Oral biology, biochemistry professors receive $2.2 million grant to find ways to repair salivary glands
10/8/24
Research, funded by NIH, focuses on stem cells to regenerate damaged glands.
SUNY Global Health Institute and Wadsworth Center to create the NYS Global Health Interface Platform
10/7/24
Partnership will provide training for future public health professionals and strengthen international grant opportunities.
UB, the Jacobs School and the Buffalo medical community mourn the loss of renowned neurosurgeon L. Nelson “Nick” Hopkins
10/7/24
L. Nelson “Nick” Hopkins, MD, SUNY Distinguished Professor and a neurosurgeon best known for changing the way stroke patients are treated, died Oct. 5. He was 81.
Study: For long COVID, lithium aspartate at low doses is ineffective, but higher doses may be promising
10/2/24
At low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID.
Results from study of first permanently implanted brain-computer interface will be presented at CNS
9/26/24
Elad Levy will present results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis at the Congress of Neurological Surgeons (CNS).
UB CAT announces R&D collaboration awards to eight life sciences companies
9/24/24
Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies
U.S. News rankings place UB 36th among public universities
9/24/24
UB comes in at No. 36 among 225 public colleges and universities, and is 76th among public and private universities.
Study: UB research identifies the likely culprit that turns classical Klebsiella pneumoniae into a devastating, drug-resistant killer
9/17/24
UB research has identified the genetic elements responsible for turning classical Klebsiella pneumoniae into a hypervirulent version, which can infect otherwise healthy people in the community.

About Us

What We Do

Partner Organizations

Visiting the Center